Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Study of Ilaprazole Dose and Duration in Contact Granuloma Caused by Laryngopharyngeal Reflux
KCT0005038Phase 4Completed
- Sponsor
- Il-Yang Pharmaceutical
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ilaprazole in Laryngeal granuloma, sponsored by Il-Yang Pharmaceutical. Started Aug 2020; status: completed.
02
Drugs
ilaprazole
03
Conditions
Laryngeal granuloma
Beyond the preview
Go deeper on KCT0005038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005038.